More interest in Indian manufacturing as Fresenius snaps up Parenteral's plant
This article was originally published in Scrip
Executive Summary
Parenteral Drugs of India, a manufacturer of intravenous infusions, tablets, syrups and injections, has divested its plant in Goa to Fresenius Kabi for Rs2 billion ($36.7 million), marking ongoing global interest in Indian manufacturing.